New blood filter could speed recovery for burn victims

NCT ID NCT07259668

Recruiting now Disease control Sponsor: Efferon JSC Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests a device called Efferon LPS that filters the blood to remove toxins and inflammatory substances in adults with severe thermal burns. Fifteen participants will receive two filtering sessions, and their outcomes will be compared to a group of similar patients from the past. The goal is to see if the device can shorten ICU stays and reduce the need for blood pressure medications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Efferon LPS device (blood filter that removes toxins and inflammatory substances)
What this could lead to: If it works, this could point toward a way to reduce ICU stays and need for blood pressure support in severe burn patients.
What could go wrong: This is a very small pilot study (15 people) with no control group from the same time period, so results may not be reliable or generalizable.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BURNS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

burn

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BURNS

Contacts and locations

Locations

State Novosibirsk Regional Clinical Hospital
RECRUITING

Novosibirsk, 630087, Russia

More trials for these conditions

Other studies related to the condition(s) this trial covers.